Analyst stock forecast
ResMed Forecast: $264.33 Analyst Target
Direct answer
ResMed's average price target is $264.33.
The target implies +10.4% from the recorded current price, and the consensus rating is Buy.
The low target implies -12.3%, the high target implies +33.6%, and the range spans 45.9% of the current price.
Forecast evidence checked November 15, 2026.
Get free ResMed email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $239.53
- Average price target
- $264.33
- High price target
- $320.00
- Low price target
- $210.00
- Low target gap
- -12.3%
- Target upside
- +10.4%
- High target gap
- +33.6%
- Target range width
- 45.9%
- Consensus rating
- Buy
- Analysts
- 17
- Evidence date
- November 15, 2026
- Valid through
- November 22, 2026
Explore related company data
Read the frequently asked questions.
What is ResMed's average price target?
ResMed's verified average price target is $264.33. The target range is $210.00 to $320.00.
How far are ResMed's low and high targets from the recorded price?
The low target implies -12.3%, while the high target implies +33.6%.
How many analysts are included in ResMed's consensus?
The verified consensus includes 17 analysts.
How is ResMed's target upside or downside calculated?
The average target of $264.33 is divided by the recorded price of $239.53, then one is subtracted to produce +10.4%. This does not guarantee a future return.
When was ResMed's analyst forecast verified?
The data was verified on 2026-11-15. The dataset is valid through 2026-11-22.